Although the formation of such chemokine heteromultimers [11] inhibits endothelial cell growth, the disruption of the proinflammatory interaction between the platelet-derived chemokines PF-4 and RANTES also alters monocyte recruitment and inhibits atherosclerosis [12]. The gene discussed is PF4; the disease is atherosclerosis.